REAL WORLD EVIDENCE

Advertisement
Dec 01 2025HEALTH

A New Hope for Eczema Sufferers: How Dupilumab is Changing the Game

Dupilumab is a game-changer for people with severe eczema. It's the first biologic drug approved for this condition. This means it's made from living organisms, not chemicals. It works by targeting specific parts of the immune system that cause inflammation. Eczema is a long-term skin condition. It

reading time less than a minute
Jul 24 2025HEALTH

Growth Hormone Therapy: A New Approach for Kids and Adults

Long-acting growth hormone (LAGH) therapy is changing the game for people with growth hormone deficiency (GHD). It's a big step forward because it means fewer injections and better treatment adherence. In Germany, three LAGH products have hit the market: lonapegsomatropin, somapacitan, and somatrog

reading time less than a minute
Jun 10 2025HEALTH

How Real-World Data Shapes Medicine Approval

Real-world evidence (RWE) is becoming a big deal in the world of medicine. It's used to back up the effectiveness of new drugs and treatments. But how exactly does it influence decisions made by regulatory bodies and health tech assessors? This is a tricky question. To find out, a special tool calle

reading time less than a minute
May 20 2025HEALTH

Connecting the Dots: Atopic Dermatitis and Gum Health

Atopic dermatitis, or eczema, is a skin condition that can cause a lot of discomfort. It is not just a skin issue. It might also affect other parts of the body. One surprising connection is with the mouth. People with atopic dermatitis may face a higher risk of periodontitis. This is a serious gum d

reading time less than a minute
May 19 2025HEALTH

The Power of Combination Therapy in Psoriasis Treatment

Psoriasis is a long-term skin condition that affects a significant number of people worldwide. Around 2-3% of the global population deals with this issue. Over the years, various treatments have been developed to manage and reduce the symptoms of psoriasis. These treatments have led to notable impro

reading time less than a minute
Feb 21 2025HEALTH

Mixed Migraine Relief: A Real-World Study

Chronic migraines are a real pain, literally. They can last for weeks or even months. People who suffer from them often try different treatments to find relief. One study looked at combining two treatments: atogepant and onabotulinumtoxinA. The goal was to see if this combo could help control chroni

reading time less than a minute
Jan 07 2025HEALTH

Faricimab Therapy and Eye Inflammation: A Year-Long Look

Let's talk about intraocular inflammation (IOI) and its link to faricimab therapy. This medication is used to treat eye conditions, but like any treatment, it can have side effects. So, what did we learn from observing patients over a year in a big hospital? Researchers wanted to get real-world insi

reading time less than a minute